20 October 2022
Top hires for VC & PE portfolio companies Q3-2022
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
Function | Focus area | Location |
---|---|---|
Chief Commercial Officer | Rapid molecular diagnostics | Belgium |
Chief Medical Officer | Radiopharmaceuticals | China |
Chief Medical Officer | Oncology biotech | US |
Country Chief Financial Officer | In/outpatient services | Austria |
Chief R&D Officer | Small molecule therapeutics | UK |
Chief Communications Officer | Medical research charity | UK |
SVP Head of Global Clinical Operations | Immuno-oncology biotech | US |
VP Intellectual Property | Protein degradation technology | UK |
VP Marketing | Big data discovery | Belgium |
Head of Clinical Operations | Anticoagulant development | Netherlands |
Head of Biology | Radiotherapeutics | Germany |
VP Telehealth | Ophthalmic technologies | France |
Director Central & Eastern Europe | Drug delivery devices | Ireland |
Innovation Project Lead, Biomarker | AI / cloud-enabled devices | France |
Newly opened projects include:
Function | Focus area | Location |
---|---|---|
CEO | Cell therapies | Switzerland |
CEO | Stem cell technologies | UK |
Chief Business Officer (US) | Regenerative medicine | France |
Chief Medical Officer | Genomic medicine | US |
Chief Scientific Officer | Oncology biotech | Switzerland |
Chief Development Officer | Cancer immunotherapies | Singapore |
Chief Financial Officer | Infectious diseases | US |
Head of Business Development | Small molecule therapeutics | UK |
VP CMC | Gene therapy | US |
Country Manager x2 | Digital patient services | Nordics |
Partner, Digital Health Investments | Life sciences investor | Italy |
Board Director x2 | Not-for-profit | UK |
Board Director | Oncology immunotherapies | France |
Board Director | Medical devices | UK |